This cross-sectional study was conducted to examine the effects of good and poor sleep quality on quality of life, depression, and fatigue in individuals with multiple sclerosis. The study was conducted at the Multiple Sclerosis (n=121) Outpatient Clinic of the Health Research and Application Center at the Trakya University between July 15, 2025, and December 30, 2025, with patients who were receiving outpatient treatment, had no communication difficulties, and agreed to participate in the study. These patients were provided with an "Informed Consent Form" "Pittsburgh Sleep Quality Index," "SF-12 Quality of Life Scale," "Beck Depression Scale," and "Fatigue Impact Scale." Participants were informed about the purpose of the study, and if they agreed to participate, they were asked to complete the questionnaire forms.
Sleep disorders are common among individuals with multiple sclerosis and negatively impact their physical and psychological well-being. This study was conducted to examine the effects of good and poor sleep quality on quality of life, depression, and fatigue in individuals with multiple sclerosis. Material and Methods: The study was conducted between july 15, 2025 and December 30, 2025 with 121 patients diagnosed with Multiple Sclerosis at the Neurology outpatient clinic of a university hospital in Edirne. Data were collected using "Patient Information Form" "Pittsburgh Sleep Quality Index," "SF-12 Quality of Life Scale," "Beck Depression Scale," and "Fatigue Impact Scale." Participants were informed about the purpose of the study, and if they agreed to participate, they were asked to complete the questionnaire forms. Financial Support: The present study was supported by the Research Fund of Trakya University. Project No: 2025/278
Study Type
OBSERVATIONAL
Enrollment
121
Trakya University Faculty of Medicine Dean'S Office Building
Merkez, Edirne, Turkey (Türkiye)
determining sleep quality
To evaluate the association between sleep quality and quality of life, depression, and fatigue in individuals with multiple sclerosis.
Time frame: 6 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.